Please ensure Javascript is enabled for purposes of website accessibility

Trump to Meet With Pharmaceutical Companies About Coronavirus

By Eric Volkman - Mar 2, 2020 at 11:16AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Representatives from Sanofi, Pfizer, and Johnson & Johnson are expected to attend the White House session Monday afternoon.

President Donald Trump will hold talks with executives from major pharmaceutical companies at 4 p.m. EDT Monday regarding the rapidly spreading SARS-CoV-2 coronavirus and the disease it causes, COVID-19. In a tweet this morning, Trump wrote: "I am meeting with the major pharmaceutical companies today at the White House about progress on a vaccine and cure. Progress being made!"

The president did not provide any details, particularly about the meeting's agenda. Nor did he specify which companies would be represented there. However, according to an article published Monday morning by Reuters, executives from Sanofi (SNY -1.63%), Pfizer (PFE -1.28%), and Johnson & Johnson (JNJ -0.77%) will attend.

Coronavirus colony.

Image source: Getty Images

In mid-February, Sanofi announced it would "leverage previous development work" with a vaccine it developed for severe acute respiratory syndrome -- aka SARS -- a disease caused by a different coronavirus that spread in the early 2000s. Johnson & Johnson is also attempting to develop a COVID-19 vaccine. Both will be collaborating with a division of the Department of Health & Human Services on their efforts. 

The COVID-19 outbreak has now claimed more than 3,000 lives around the world. On Sunday night, a second death in the U.S. from the illness was reported -- a man in his 70s living in a nursing facility near Seattle. The most recent reports document 88 confirmed cases of the disease in this country.

President Trump has formed a coronavirus task force to lead the U.S. government's response to COVID-19; it is headed by Vice President Mike Pence.

The broader stock market was up by almost 3% at midday Monday following last week's plunge. Share prices of the three drugmakers expected to participate in the White House meeting were up by similar percentages -- Sanofi by 3.7%, Pfizer by 3.6%, and Johnson & Johnson by 2.4%.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Pfizer Inc. Stock Quote
Pfizer Inc.
$51.64 (-1.28%) $0.67
Johnson & Johnson Stock Quote
Johnson & Johnson
$178.14 (-0.77%) $-1.38
Sanofi Stock Quote
$50.18 (-1.63%) $0.83

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.